The short answer
Review kava before adding it to asenapine, especially if you already feel sleepy, dizzy or unsteady. The exact combination’s risk has not been quantified.
What this answer covers
Oral kava supplement with maleate sublingual tablets or asenapine transdermal system, distinguished by route; botanical preparation and medicine route retained.
- Supplement or preparation
- Piper methysticum
- Medication ingredient
- asenapine
Why alertness deserves review
Asenapine has cognitive or motor impairment precautions. Kava guidance raises alertness concerns, so your symptoms and other medicines matter.
A negative driving result has limits
A small study found no driving impairment with its kava preparation compared with placebo. Oxazepam was a separate comparator, not a combined exposure with this medicine.
Identify the complete product
Bring the amount, preparation and other ingredients to the pharmacist. These sources do not provide a universal safe dose or a protective gap between the supplement and medicine.
Watch for impaired alertness
Asenapine can affect alertness and coordination. Avoid driving if affected and contact the prescriber if added sleepiness, confusion or unsteadiness appears after a new product. Severe confusion, fainting or inability to wake needs urgent assessment.
Route does not settle supplement safety
Patch and sublingual asenapine have different concentration profiles. Small route studies found variable somnolence; they did not test this supplement or prove the patch eliminates impairment.
Evidence and practical considerations
Side effects & toxicity
Conditional alertness review based on exact medication effects and supplement precautions; not proven pair-specific CNS depression.
- Exact scope
- Oral kava supplement with maleate sublingual tablets or asenapine transdermal system, distinguished by route; botanical preparation and medicine route retained. with Exact asenapine maleate sublingual tablets or asenapine transdermal system, distinguished by route. Exact RxNorm IN784649; SAPHRIS maleate sublingual tablet and SECUADO asenapine transdermal system distinguished. Do not assign swallowed-tablet or sublingual food/drink instructions to the patch.
- Medication form and route
- sublingual; transdermal
- Timing or duration
- Source-specific single-dose, repeated-dose and observational exposures distinguished.
What remains uncertain
- No exact-pair co-use trial identified; standalone or other-medicine findings and product differences prevent a uniform risk estimate.
Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed asenapine.
Somnolence, orthostatic and QT precautions. UGT1A4 and CYP1A2 major metabolism; no dose adjustment advised with CYP3A4 inducers based on PK studies. Do not eat or drink for ten minutes after a sublingual dose.
How this applies: Exact asenapine maleate sublingual route; patch instructions require the separate SECUADO label.
No supplement-specific event rate, universal timing rule or untested route/preparation equivalence.
Source 2: official guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: People considering the specified supplement.
Advises against use with sedative substances. Kava may cause dizziness and has been linked to rare severe liver injury, including with different extraction methods.
How this applies: Preparation-specific evidence; exact asenapine co-use is not inferred from another medicine or route.
Not a asenapine study. Intrinsic liver risk does not establish added asenapine hepatotoxicity; preparation and co-exposure vary.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Twenty-two adults in a randomized crossover driving study.
Medicinal-dose kava did not significantly impair driving outcomes; oxazepam impaired some outcomes.
How this applies: Preparation-specific evidence; exact asenapine co-use is not inferred from another medicine or route.
Not combined administration or evidence that all kava preparations lack impairment.
Source 4: official product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Adults with schizophrenia prescribed asenapine patches.
Somnolence, cognitive/motor, orthostatic and QT precautions; clinical interaction data include studies of sublingual asenapine.
How this applies: Exact ingredient in a distinct transdermal formulation; route bridge kept explicit.
No exact supplement interaction study; sublingual food/drink interval cannot be assigned to the patch.
Source 5: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Three phase-1 studies in healthy adults and adults with schizophrenia.
Patch produced smoother concentrations and lower peaks; somnolence varied among studies and was not uniformly absent.
How this applies: Only the named drug, preparation, route and measured endpoints apply.
No supplement co-use; small PK studies do not establish a universal sedation advantage or combination safety.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Research summary published | |
| Article prepared | |
| Current exact available claims adjudicated using original captures and explicit identity and comparator limits. |
Article revision: 96247bd9898ea873
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.